Analysis and characterization of enzymes and nucleic acids

Principles and Methods of Toxicology: Fifth Edition

Volumn , Issue , 2007, Pages 1973-2040

  Guengerich, F Peter ^a   Bartleson, Cheryl J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85083761724     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (364)

1. Guengerich, F. P., Microsomal enzymes involved in toxicology: analysis and separation, in Principles and Methods of Toxicology, 1st ed., Hayes, A. W., Ed., Raven Press, New York, 1982, pp. 609-634.
2. Guengerich, F. P., Analysis and characterization of enzymes, in Principles and Methods of Toxicology, 2nd ed., Hayes, A. W., Ed., Raven Press, New York, 1989, pp. 777-814.
3. Guengerich, F. P., Analysis and characterization of enzymes, in Principles and Methods of Toxicology, 3rd ed., Hayes, A. W., Ed., Raven Press, New York, 1994, pp. 1259-1313.
4. Guengerich, F. P., Analysis and characterization of enzymes and nucleic acids, in Principles and Methods of Toxicology, 4th ed., Hayes, A. W., Ed., Taylor & Francis, Philadelphia, PA, 2001, pp. 1625-1687.
5. Miller, E. C. and Miller, J. A., The presence and significance of bound amino azodyes in the livers of rats fed p-dimethylaminoazobenzene, Cancer Res., 7, 468-480, 1947.
6. Guengerich, F. P., Introduction and historical perspective, in Biotransformation, Vol. 3, Guengerich, F. P., Ed., in Comprehensive Toxicology, Vol. 3, Biotransformation, Guengerich, F. P., Ed., Elsevier Science, Oxford, 1997, pp. 1-6.
7. Jakoby, W. B., Ed., Enzymatic Basis of Detoxication, Vols. 1 and 2, Academic Press, New York, 1980.
8. Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., and Baillie, T. A., Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development, Chem. Res. Toxicol., 17, 3-16, 2004.
9. Guengerich, F. P., Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity, Chem. Res. Toxicol., 14, 611-650, 2001.
10. Guengerich, F. P., Principles of covalent binding of reactive metabolites and examples of activation of bis-electrophiles by conjugation, Arch. Biochem. Biophys., 433, 369-378, 2005.
11. Liebler, D. C. and Guengerich, F. P., Mechanisms of drug-induced cell damage, Nature Rev. Drug Discov., 4, 410-420, 2005.
12. Borzelleca, J. F., Profiles in toxicology: Paracelsus, herald of modern toxicology, Toxicol. Sci., 53, 2-4, 2000.
13. Guengerich, F. P., Life and times in biochemical toxicology, Int. J. Toxicol., 24, 1-17, 2005.
14. Harvison, P. J., Guengerich, F. P., Rashed, M. S., and Nelson, S. D., Cytochrome P-450 isozyme selectivity in the oxidation of acetaminophen, Chem. Res. Toxicol., 1, 47-52, 1988.
15. Patten, C. J., Thomas, P. E., Guy, R. L., Lee, M., Gonzalez, F. J., Guengerich, F. P., and Yang, C. S., Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics, Chem. Res. Toxicol., 6, 511-518, 1993.
16. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B., Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism, J. Pharmacol. Exp. Ther., 187, 185-194, 1973.
17. Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B., Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo, J. Pharmacol. Exp. Ther., 187, 195-202, 1973.
18. Streeter, A. J., Bjorge, S. M., Axworthy, D. B., Nelson, S. D., and Baillie, T. A., The microsomal metabolism and site of covalent binding to protein of 3'-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen, Drug Metab. Dispos., 12, 565-576, 1984.
19. Roberts, S. A., Price, V. F., and Jollow, D. J., Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide, Toxicol. Appl. Pharmacol., 105, 195-208, 1990.
20. Qiu, Y., Benet, L. Z., and Burlingame, A. L., Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry, J. Biol. Chem., 273, 17940-17953, 1998.
21. Cook, J. W., Hewett, C. L., and Hieger, I., The isolation of a cancer-producing hydrocarbon from coal tar, Parts I, II, and III, J. Chem. Soc., 394-405, 1933.
22. 1 exo-8,9-epoxide and relevance to toxicity and detoxication, Drug Metab. Rev., 31, 141-158, 1999.
23. 1 oxidation products with lysine, Chem. Res. Toxicol., 15, 780-792, 2002.
24. Egner, P. A., Munoz, A., and Kensler, T. W., Chemoprevention with chlorophyllin in individuals exposed to dietary anatoxin, Mutat. Res., 523-524, 209-216, 2003.
25. 1 metabolism in human hepatocytes in primary culture, Cancer Res., 55, 5574-5579, 1995.
26. Kwak, M. K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., and Kensler, T. W., Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: identification of novel gene clusters for cell survival, J. Biol. Chem., 278, 8135-8145, 2003.
27. Guengerich, F. P. and Macdonald, T. L., Chemical mechanisms of catalysis by cytochromes P-450: a unified view, Acct. Chem. Res., 17, 9-16, 1984.
28. Ortiz De Montellano, P. R., Ed., Cytochrome P450: Structure, Mechanism, and Biochemistry, 3rd ed., Kluwer Academic/Plenum Publishers, New York, 2005.
29. Ortiz de Montellano, P. R. and Correia, M. A., Suicidal destruction of cytochrome P-450 during oxidative drug metabolism, Annu. Rev. Pharmacol. Toxicol., 23, 481-503, 1983.
30. Correia, M. A. and Ortiz de Montellano, P. R., Inhibition of cytochrome P450 enzymes, in Cytochrome P450: Structure, Mechanism, and Biochemistry, Ortiz de Montellano, P. R., Ed., Kluwer Academic/Plenum Publishers, New York, 2005, pp. 247-322.
31. Wislocki, P. G., Miwa, G. T., and Lu, A. Y. H., Reactions catalyzed by the cytochrome P-450 system, in Enzymatic Basis of Detoxication, Vol. 1, Jakoby, W. B., Ed., Academic Press, New York, 1980, pp. 135-182.
32. Guengerich, F. P., Human cytochrome P450 enzymes, in Cytochrome P450: Structure, Mechanism, and Biochemistry, Ortiz de Montellano, P. R., Ed., Kluwer Academic/Plenum Publishers, New York, 2005, pp. 377-531.
33. Rendic, S., Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metab. Rev., 34, 83-448, 2002.
34. Jakoby, W. B., Detoxication enzymes, in Enzymatic Basis of Detoxication, Vol. 1, Jakoby, W. B., Ed., Academic Press, New York, 1980, pp. 1-6.
35. Guengerich, F. P., Human cytochrome P450 enzymes, in Cytochrome P450: Structure, Mechanism, and Biochemistry, Ortiz de Montellano, P. R., Ed., Kluwer Academic/Plenum Publishers, New York, 2005, pp. 377-531.
36. Guengerich, F. P. and Liebler, D. C., Enzymatic activation of chemicals to toxic metabolites, CRC Crit. Rev. Toxicol., 14, 259-307, 1985.
37. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W., P450 superfamily: update on new sequences, gene mapping, accession numbers, and nomenclature, Pharmacogenetics, 6, 1-42, 1996.
38. coh substrate specificity by mutation of a single amino-acid residue, Nature, 339, 632-634, 1989.
39. Distlerath, L. M. and Guengerich, F. P., Enzymology of human liver cytochromes P-450, in Mammalian Cytochromes P-450, Vol. 1, Guengerich, F. P., Ed., CRC Press, Boca Raton, FL, 1987, pp. 133-198.
40. Guengerich, F. P., Effects of nutritive factors on metabolic processes involving bioactivation and detoxication of chemicals, Annu. Rev. Nutr., 4, 207-231, 1984.
41. Guengerich, F. P., Human cytochrome P-450 3A4: regulation and role in drug metabolism, Annu. Rev. Pharmacol. Toxicol., 39, 1-17, 1999.
42. Müller-Enoch, D., Churchill, P., Fleischer, S., and Guengerich, F. P., Interaction of liver microsomal cytochrome P-450 and NADPH-cytochrome P-450 reductase in the presence and absence of lipid, J. Biol. Chem., 259, 8174-8182, 1984.
43. Halvorson, M., Greenway, D., Eberhart, D., Fitzgerald, K., and Parkinson, A., Reconstitution of testosterone oxidation by purified rat cytochrome P450p (IIIA1), Arch. Biochem. Biophys., 277, 166-180, 1990.
44. Imaoka, S., Imai, Y., Shimada, T., and Funae, Y., Role of phospholipids in reconstituted cytochrome P450 3A forms and mechanism of their activation of catalytic activity, Biochemistry, 31, 6063-6069, 1992.
45. Nebert, D. W., Nelson, D. R., Coon, M. J., Estabrook, R. W., Feyereisen, R., Fujii-Kuriyama, Y., Gonzalez, F. J., Guengerich, F. P., Gunsalus, I. C., Johnson, E. F. et al., The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature, DNA Cell Biol., 10, 397-398, 1991.
46. Guengerich, F. P., Cytochrome P-450 enzymes and drug metabolism, in Progress in Drug Metabolism, Vol. 10, Bridges, J. W., Chasseaud, L. F., and Gibson, G. G., Eds., Taylor & Francis, London, 1987, pp. 1-54.
47. Dannan, G. A., Guengerich, F. P., Kaminsky, L. S., and Aust, S. D., Regulation of cytochrome P-450: immunochemical quantitation of eight isozymes in liver microsomes of rats treated with polybrominated biphenyl congeners, J. Biol. Chem., 258, 1282-1288, 1983.
48. Guengerich, F. P. et al., Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or ß-naphthoflavone, Biochemistry 21, 6019-6030, 1982.
49. 4-steroid 5a-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450, J. Biol. Chem., 261, 10728-10735, 1986.
50. Waxman, D. J., Dannan, G. A., and Guengerich, F. P., Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes, Biochemistry, 24, 4409-4417, 1985.
51. Waterman, M. R. and Guengerich, F. P., Enzyme regulation, in Comprehensive Toxicology, Vol. 3, Biotransformation, Guengerich, F. P., Ed., Elsevier Science, Oxford, 1997, pp. 7-14.
52. Williams, S. N., Dunham, E., and Bradfield, C. A., Induction of P450 enzymes: receptors, in Cytochrome P450: Structure, Mechanism, and Biochemistry, Ortiz De Montellano, P. R., Ed., Kluwer Academic/Plenum Publishers, New York, 2005, pp. 323-346.
53. White, P. C., New, M. I., and Dupont, B., HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation, Proc. Natl. Acad. Sci. U.SA., 81, 7505-7509, 1984.
54. Keeney, D. S. and Waterman, M. R., Regulation of steroid hydroxylase gene expression: importance to physiology and disease, Pharmacol. Ther., 58, 301-317, 1993.
55. Shimada, T., Yamazaki, H., Foroozesch, M., Hopkins, N. E., Alworth, W. L., and Guengerich, F. P., Selectivity of polycyclic inhibitors for human cytochromes P450 1A1, 1A2, and 1B1, Chem. Res. Toxicol., 11, 1048-1056, 1998.
56. Newton, D. J., Wang, R. W., and Lu, A. Y. H., Cytochrome P450 inhibitors: evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes, Drug Metab. Dispos., 23, 154-158, 1994.
57. McManus, M. E., Burgess, W. M., Veronese, M. E., Huggett, A., Quattrochi, L. C., and Tukey, R. H., Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450, Cancer Res, 50, 3367-3376, 1990.
58. Yamazaki, H., Inui, Y., Yun, C.-H., Mimura, M., Guengerich, F. P., and Shimada, T., Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes, Carcinogenesis, 13, 1789-1794, 1992.
59. Armstrong, R. N., Structure, catalytic mechanism, and evolution of the glutathione transferases, Chem. Res. Toxicol., 10, 2-18,1997.
60. Hayes, J. D., Flanagan, J. U., and Jowsey, I. R., Glutathione transferases, Annu. Rev. Pharmacol. Toxicol., 45, 51-88, 2005.
61. Burchell, B., McGurk, K., Brierly, C. H., and Clarke, D. J., UDP-glucuronosyltransferases, in Comprehensive Toxicology, Vol. 3, Biotransformation, Guengerich, F. P., Ed., Oxford, 1997, pp. 401-135.
62. Hammock, B. D., Grant, D. F., and Storms, D. H., Epoxide hydrolases, in Comprehensive Toxicology, Vol. 3, Biotransformation, Guengerich, F. P., Ed., Oxford, 1997, pp. 283-305.
63. Williams, D. E., Hale, S. E., Muerhoff, A. S., and Masters, B. S. S., Rabbit lung flavin-containing monooxygenase: purification, characterization, and induction during pregnancy, Mol. Pharmacol, 28, 381-390, 1985.
64. Cashman, J. R., Monoamine oxidase and flavin-containing monooxygenases, in Comprehensive Toxicology, Vol. 3, Biotransformation, Guengerich, F. P., Ed., Oxford, 1997, pp. 69-96.
65. Porter, T. D. and Kasper, C. B., Coding nucleotide sequence of rat NADPH-cytochrome P-450 oxidoreductase cDNA and identification of flavin-binding domains, Proc. Natl. Acad. Sci. USA., 82, 973-977, 1985.
66. Williams, R. T., Detoxication Mechanisms, 2nd ed., Wiley, New York, 1959.
67. Josephy, P. D., Guengerich, F. P., and Miners, J. O., Phase 1 and phase 2 drug metabolism: terminology that we should phase out, Drug Metab. Rev., 37, 579-584, 2005.
68. Geiger, L. E., Hogy, L. L., and Guengerich, F. P., Metabolism of acrylonitrile by isolated rat hepatocytes, Cancer Res., 43, 3080-3087, 1983.
69. Guengerich, F. P., Geiger, L. E., Hogy, L. L., and Wright, P. L., In vitro metabolism of acrylonitrile to 2-cyanoethylene oxide, reaction with glutathione, and irreversible binding to proteins and nucleic acids, Cancer Res., 41, 4925-4933, 1981.
70. Hogy, L. L. and Guengerich, F. P., In vivo interaction of acrylonitrile and 2-cyanoethylene oxide with DNA in rats, Cancer Res., 46, 3932-3938, 1986.
71. 2-ethenoguanine and 5,6,7,9-tetrahydro-7-hydroxy-9-oxoimidazo[1,2-a]purine in DNA treated with 2-chlorooxirane by high-performance liquid chromatography/mass spectrometry and comparison of amounts with other adducts, Chem. Res. Toxicol., 10, 242-247, 1997.
72. 4-ethenocytosine, and 4-amino-5-(imi-dazol-2-yl)imidazole, Biochemistry, 32, 12793-12801, 1993.
73. 2-ethenoguanine, 5,6,7,9-tetrahy-dro-9-oxoimidazo[1,2-a]purine, and 5,6,7,9-tetrahydro-7-hydroxy-9-oxoimidazo[1,2-a]purine, Biochemistry, 37, 5184-5193, 1998.
74. Guengerich, F. P., Crawford, Jr., W. M., and Watanabe, P. G., Activation of vinyl chloride to covalently bound metabolites: roles of 2-chloroethylene oxide and 2-chloroacetal-dehyde, Biochemistry, 18, 5177-5182, 1979.
75. Liebler, D. C. and Guengerich, F. P., Olefin oxidation by cytochrome P-450: evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene, Biochemistry, 22, 5482-5489, 1983.
76. Miller, R. E. and Guengerich, F. P., Metabolism of trichlo-roethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450, Cancer Res., 43, 1145-1152, 1983.
77. Guengerich, F. P., Mason, P. S., Stott, W. T., Fox, T. R., and Watanabe, P. G., Roles of 2-haloethylene oxides and 2-haloacetaldehydes derived from vinyl bromide and vinyl chloride in irreversible binding to protein and DNA, Cancer Res., 41, 4391-4398, 1981.
78. Guengerich, F. P., Kim, D.-H., and Iwasaki, M., Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects, Chem. Res. Toxicol., 4, 168-179, 1991.
79. van Bladeren, P. J., Breimer, D. D., van Huijgevoort, J. A. T. C. M., Vermeulen, N. P. E., and van der Gen, A., The metabolic formation of N-acetyl-S-2-hydroxyethyl-l-cys-teine from tetradeutero-1,2-dibromoethane: relative importance of oxidation and glutathione conjugation in vivo, Biochem. Pharmacol., 30, 2499-2502, 1981.
80. 7-gua-nyl)ethyl]glutathione, Cancer Res., 46, 2839-2844, 1986.
81. 7-guanyl)ethyl]-N-acetylcysteine in urine following administration of ethylene dibromide to rats, Cancer Res., 49, 5843-5851, 1989.
82. 7-guanyl)ethyl]glutathione in DNA, J. Am. Chem. Soc., 110, 3284-3291, 1988.
83. Guengerich, F. P., Activation of dihaloalkanes by thiol-dependent mechanisms, J. Biochem. Mol. Biol., 36, 20-27, 2003.
84. Cmarik, J. L., Inskeep, P. B., Meyer, D. J., Meredith, M. J., Ketterer, B., and Guengerich, F. P., Selectivity of rat and human glutathione S-transferases in activation of ethylene dibromide by glutathione conjugation and DNA binding and induction of unscheduled DNA synthesis in human hepatocytes, Cancer Res., 50, 2747-2752, 1990.
85. 7-guanyl)ethyl]glutathione adduct in glu-tathione-mediated binding of 1,2-dibromoethane to DNA, Proc. Natl. Acad. Sci. U.S.A., 80, 5266-5270, 1983.
86. 7-guanyl)ethyl]glutathione, the major DNA adduct formed from 1,2-dibromoethane, Biochemistry, 25, 2192-2198, 1986.
87. 1 by constitutive forms of cytochrome P-450 in rat liver microsomes, Toxicol. Appl. Pharmacol., 91, 13-21, 1987.
88. Bolt, H. M., Metabolism of estrogens: natural and synthetic, Pharmacol. Ther., 4, 155-181, 1979.
89. Shah, R. R., Oates, N. S., Idle, J. R., Smith, R. L., Dayer, P., Courvoisier, F., Balant, L., and Fabre, J., Beta-blockers and drug oxidation status, Lancet, 508-509, 1982.
90. Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J., and Hetzel, M. R., Metabolic oxidation phenotypes as markers for susceptibility to lung cancer, Nature, 312, 169-170, 1984.
91. Idle, J. R., Mahgoub, A., Sloan, T. P., Smith, R. L., Mbanefo, C. O., and Bababunmi, E. A., Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer, Cancer Lett., 11, 331-338, 1981.
92. Gonzalez, F. J. and Meyer, U. A., Molecular genetics of the debrisoquin-sparteine polymorphism, Clin. Pharmacol. Ther., 50, 233-238, 1991.
93. Guengerich, F. P., Studies on the activation of a model furan compound: toxicity and covalent binding of 2-(N-ethylcarbamoylhydroxymethyl)furan, Biochem. Pharmacol., 26, 1909-1915, 1977.
94. van der Hoeven, T. A. and Coon, M. J., Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes, J. Biol. Chem., 249, 6302-6310, 1974.
95. Fang, W. F. and Strobel, H. W., The drug and carcinogen metabolism system of rat colon microsomes, Arch. Biochem. Biophys., 186, 128-138, 1978.
96. 2-sedi-mented microsomes from rat liver, Biochem. Pharmacol., 21, 3249-3256, 1972.
97. Jernström, B., Capdevila, J., Jakobsson, S., and Orrenius, S., Solubilization and partial purification of cytochrome P-450 from rat lung microsomes, Biochem. Biophys. Res. Commun., 64, 814-822, 1975.
98. Taugen, O., Jonasson, J., and Orrenius, S., Isolation of rat liver microsomes by gel filtration, Anal. Biochem., 54, 597-603, 1973.
99. Wang, P. P., Beaune, P., Kaminsky, L. S., Dannan, G. A., Kadlubar, F. F., Larrey, D., and Guengerich, F. P., Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes, Biochemistry, 22, 5375-5383, 1983.
100. Omura, T. and Sato, R., The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemopro-tein nature, J. Biol. Chem., 239, 2370-2378, 1964.
101. Haugen, D. A. and Coon, M. J., Properties of electrophoret-ically homogenous phenobarbital-inducible and ß-naph-thoflavone-inducible forms of liver microsomal cytochrome P-450, J. Biol. Chem., 251, 7929-7939, 1976.
102. Ryan, D., Lu, A. Y. H., West, S., and Levin, W., Multiple forms of cytochrome P-450 in phenobarbital- and 3-meth-ylcholanthrene-treated rats, J. Biol. Chem., 250, 2157-2163, 1975.
103. Omura, T. and Sato, R., Isolation of cytochromes P-450 and P-420, Meth. Enzymol., 10, 556-561, 1967.
104. Matsubara, T., Koike, M., Touchi, A., Tochino, Y., and Sugeno, K., Quantitative determination of cytochrome P-450 in rat liver homogenate, Anal. Biochem., 75, 596-603, 1976.
105. Johannesen, K. A. M. and DePierre, J. W., Measurements of cytochrome P-450 in the presence of large amounts of contaminating hemoglobin and methemoglobin, Anal. Biochem., 86, 725-732, 1978.
106. Phillips, A. H. and Langdon, R. G., Hepatic triphosphopy-ridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies, J. Biol. Chem., 237, 2652-2660, 1962.
107. Vermilion, J. L. and Coon, M. J., Purified liver microsomal NADPH-cytochrome P-450 reductase: spectral characterization of oxidation-reduction states, J. Biol. Chem., 253, 2694-2704, 1978.
108. Roerig, D. L., Mascaro, Jr., L., and Aust, S. D., Microsomal electron transport: tetrazolium reduction by rat liver microsomal NADPH-cytochrome c reductase, Arch. Biochem. Biophys., 153, 475-479, 1972.
109. Nash, T., The colorimetric estimation of formaldehyde by means of the Hantzsch reaction, Biochem. J., 55, 416-421, 1953.
110. Cochin, J. and Axelrod, J., Biochemical and pharmacological changes in the rat following chronic administration of morphine, nalorphine, and normorphine, J. Pharmacol. Exp. Ther., 125, 105-110, 1959.
111. Lu, A. Y. H. and West, S. B., Reconstituted mammalian mixed-function oxidases: requirements, specificities and other properties, Pharmacol. Ther., 2, 337-358, 1978.
112. Guengerich, F. P., Ballou, D. P., and Coon, M. J., Purified liver microsomal cytochrome P-450: electron-accepting properties and oxidation-reduction potential, J. Biol. Chem., 250, 7405-7414, 1975.
113. Guengerich, F. P. and Holladay, L. A., Hydrodynamic characterization of highly purified and functionally active liver microsomal cytochrome P-450, Biochemistry, 18, 5442-5449, 1979.
114. Thomas, P. E., Bandiera, S., Maines, S. L., Ryan, D. E., and Levin, W., Regulation of cytochrome P-450j, a high-affinity N-nitrosodimethylamine demethylase, in rat hepatic microsomes, Biochemistry, 26, 2280-2289, 1987.
115. Yoo, J. S. H., Guengerich, F. P., and Yang, C. S., Metabolism of N-nitrosodialkylamines by human liver microsomes, Cancer Res., 48, 1499-1504, 1988.
116. Lu, A. Y. H., Strobel, H. W., and Coon, M. J., Properties of a solubilized form of the cytochrome P-450-containing mixed-function oxidase of liver microsomes, Mol. Pharmacol., 6, 213-220, 1970.
117. Nordblom, G. D. and Coon, M. J., Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450, Arch. Biochem. Biophys., 180, 343-347, 1977.
118. Kamataki, T., Lin, M. L., Belcher, D. H., and Neal, R. A., Studies of the metabolism of parathion with an apparently homogeneous preparation of rabbit liver cytochrome P-450, Drug Metab. Dispos., 4, 180-189, 1976.
119. Greenlee, W. F. and Poland, A., An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetra-chlorodibenzo-p-dioxin, J. Pharmacol. Exp. Ther., 205, 596-605, 1978.
120. Guengerich, F. P., Separation and purification of multiple forms of microsomal cytochrome P-450: partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbital- and 3-methyl-cholanthrene-treated rats, J. Biol. Chem., 253, 7931-7939, 1978.
121. Nebert, D. W. and Gelboin, H. V., Substrate-inducible microsomal arylhydroxylase in mammalian cell culture: assay and properties of induced enzyme, J. Biol. Chem., 243, 6242-6249, 1968.
122. Dehnen, W., Tomingas, R., and Roos, J., A modified method for the assay of benzo(a)pyrene hydroxylase, Anal. Biochem., 53, 373-383, 1973.
123. DePierre, J. W., Johannesen, K. A. M., Moron, M. S., and Seidegård, J., Radioactive assay of aryl hydrocarbon monooxygenase and epoxide hydrase, Meth. Enzymol., 52, 412-418, 1978.
124. Selkirk, J. K., Croy, R. G., Roller, P. P., and Gelboin, H. V., High-pressure liquid chromatographic analysis of benzo(a)pyrene metabolism and covalent binding and the mechanism of action of 7,8-benzoflavone and 1,2-epoxy-3,3,3-trichloropropane, Cancer Res., 34, 3474-3480, 1974.
125. Thakker, D. R., Yagi, H., and Jerina, D. M., Analysis of polycyclic aromatic hydrocarbons and their metabolites by high-pressure liquid chromatography, Meth. Enzymol., 52, 279-296, 1978.
126. Bauer, E., Guo, Z., Ueng, Y.-F., Bell, L. C., and Guenger-ich, F. P., Oxidation of benzo(a)pyrene by recombinant human cytochrome P450 enzymes, Chem. Res. Toxicol., 8, 136-142, 1995.
127. Deutsch, J., Leutz, J. C., Yang, S. K., Gelboin, H. V., Chiang, Y. L., Vatsis, K. P., and Coon, M. J., Regio- and stereoselectivity of various forms of purified cytochrome P-450 in the metabolism of benzo(a)pyrene and (-)trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene as shown by product formation and binding to DNA, Proc. Natl. Acad. Sci. USA, 75, 3123-3127, 1978.
128. Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P., Wolff, T., and Waxman, D. J., Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism, J. Biol. Chem, 261, 5051-5060, 1986.
129. Böcker, R. H. and Guengerich, F. P., Oxidation of 4-aryl-and 4-alkyl-substituted 2,6-dimethyl-3,5-bis(alkoxycarbo-nyl)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450, J. Med. Chem, 29, 1596-1603, 1986.
130. Guengerich, F. P., Brian, W. R., Iwasaki, M., Sari, M.-A., Bäärnhielm, C., and Berntsson, P., Oxidation of dihydro-pyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4, J. Med. Chem., 34, 1838-1844, 1991.
131. Peter, R., Böcker, R. G., Beaune, P. H., Iwasaki, M., Guengerich, F. P., and Yang, C.-S., Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 IIE1, Chem. Res. Toxicol., 3, 566-573, 1990.
132. O'Shea, D., Davis, S. N., Kim, R. B., and Wilkinson, G. R., Effect of fasting and obesity in humans on the 6-hydrox-ylation of chloroxazone: a putative probe of CYP2E1 activity, Clin. Pharmacol. Ther., 56, 359-367, 1994.
133. Kim, R. B., Yamazaki, H., Mimura, M., Shimada, T., Guengerich, F. P., Chiba, K., Ishizaki, T., and Wilkinson, G. R., Chlorzoxazone 6-hydroxylation in Japanese and Caucasians: in vitro and in vivo differences, J. Pharmacol. Exp. Ther., 279, 4-11, 1996.
134. Walsh, C., Enzymatic Reaction Mechanisms, W.H. Freeman, San Francisco, CA, 1979.
135. Guengerich, F. P., Enzymatic oxidation of xenobiotic chemicals, CRC Crit. Rev. Biochem. Mol. Biol., 25, 97-153, 1990.
136. Okazaki, O. and Guengerich, F. P., Evidence for specific base catalysis in N-dealkylation reactions catalyzed by cytochrome P450 and chloroperoxidase: differences in rates of deprotonation of aminium radicals as an explanation for high kinetic hydrogen isotope effects observed with peroxidases, J. Biol. Chem., 268, 1546-1552, 1993.
137. Guengerich, F. P., Yun, C.-H., and Macdonald, T. L., Evidence for a one-electron oxidation mechanism in N-dealkylation of N,N-dialkylanilines by cytochrome P450 2B1: kinetic hydrogen isotope effects, linear free energy relationships, comparisons with horseradish peroxidase, and studies with oxygen surrogates, J. Biol. Chem., 271, 27321-27329, 1996.
138. Miwa, G. T., Walsh, J. S., Kedderis, G. L., and Hollenberg, P. F., The use of intramolecular isotope effects to distinguish between deprotonation and hydrogen atom abstraction mechanisms in cytochrome P-450- and peroxidase-catalyzed N-demethylation reactions, J. Biol. Chem., 258, 14445-14449, 1983.
139. 5 on steady-state kinetics, J. Biol. Chem., 272, 29643-29651, 1997.
140. 6-ethenoadenosine, Chem. Res. Toxicol., 4, 413-421, 1991.
141. Dahl, G. A., Miller, J. A., and Miller, E. C., Vinyl carbam-ate as a promutagen and a more carcinogenic analog of ethyl carbamate, Cancer Res., 38, 3793-3804, 1978.
142. Dahl, G. A., Miller, E. C., and Miller, J. A., Comparative carcinogenicities and mutagenicities of vinyl carbamate, ethyl carbamate, and ethyl N-hydroxycarbamate, Cancer Res., 40, 1194-1203, 1980.
143. 6-Ethenoadenosine formation, mutagenicity and murine tumor induction as indicators of the generation of an electrophilic epoxide metabolite of the closely related carcinogens ethyl carbamate (urethane) and vinyl carbamate, Carcinogenesis, 11, 463-473, 1990.
144. Yoo, J. S. H., Cheung, R. J., Patten, C. J., Wade, D., and Yang, C. S., Nature of N-nitrosodimethylamine demethylase and its inhibitors, Cancer Res., 47, 3378-3383, 1987.
145. Udenfriend, S., Fluoresence Assay in Biology and Medicine, Academic Press, New York, 1969.
146. 6-ethenoadenine-forming metabolites, Anal. Biochem., 150, 379-393, 1985.
147. 3 group on the enzymic demethylation of o-nitroanisole, Biochim. Biophys. Acta, 136, 566-567, 1967.
148. Miller, G. P. and Guengerich, F. P., Binding and oxidation of alkyl 4-nitrophenyl ethers by rabbit cytochrome P450 1A2: evidence for two binding sites, Biochemistry, 40, 7262-7272, 2001.
149. Yamano, S., Tatsuno, J., and Gonzalez, F. J., The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes, Biochemistry, 29, 1322-1329, 1990.
150. Yun, C.-H., Shimada, T., and Guengerich, F. P., Purification and characterization of human liver microsomal cytochrome P-450 2A6, Mol. Pharmacol., 40, 679-685, 1991.
151. Yun, C.-H., Kim, K.-H., Calcutt, M. W., and Guengerich, F. P., Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6, J. Biol. Chem., 280, 12279-12291, 2005.
152. Wandel, C., Witte, J. S., Hall, J. M., Stein, C. M., Wood, A. J., and Wilkinson, G. R., CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism, Clin. Pharmacol. Ther., 68, 82-91, 2000.
153. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 243, 1331-1332, 1951.
154. Sun, J. D. and Dent, J. G., A new method for measuring covalent binding of chemicals to cellular macromolecules, Chem. Biol. Interact., 32, 41-61, 1980.
155. Wallin, H., Schelin, C., Tunek, A., and Jergil, B., A rapid and sensitive method for determination of covalent binding of benzo(a)pyrene to proteins, Chem. Biol. Interact., 38, 109-118,1981.
156. Guengerich, F. P., Crawford, Jr., W. M., Domoradzki, J. Y., Macdonald, T. L., and Watanabe, P. G., In vitro activation of 1,2-dichloroethane by microsomal and cytosolic enzymes, Toxicol. Appl. Pharmacol., 55, 303-317, 1980.
157. Inskeep, P. B. and Guengerich, F. P., Glutathione-mediated binding of dibromoalkanes to DNA: specificity of rat glu-tathione S-transferases and dibromoalkane structure, Carcinogenesis, 5, 805-808, 1984.
158. Dische, Z., Color reactions of nucleic acid components, in The Nucleic Acids, Vol. 1, Chargoff, E. and Davidson, J. N. Academic Press, New York, 1955, pp. 285-305.
159. Cerasone, C. F., Bolognesi, C., and Santi, L., Improved microfluorometric DNA determinations in biological material using 33258 Hoechst, Anal. Biochem., 100, 188-197, 1979.
160. Shimada, T., Oda, Y., Yamazaki, H., Mimura, M., and Guengerich, F. P., SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA 1535/pSK1002, NM2009, and NM3009, in Methods in Molecular Genetics, Vol. 5, Gene and Chromosome Analysis, Adolph, K. W., Ed., Academic Press, Orlando, FL, 1994, pp. 342-355.
161. Josephy, P. D., Evans, D. H., Parikh, A., and Guengerich, F. P., Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltrans-ferase in Escherichia coli, Chem. Res. Toxicol., 11, 70-74, 1998.
162. 32P-labeling test for DNA damage, Proc. Natl. Acad. Sci. U.S.A., 78, 6126-6129, 1981.
163. 35S]methionine: analysis of DNA adducts of 4-aminobiphenyl, Proc. Natl. Acad. Sci. U.S.A., 91, 1696-1700, 1994.
164. Guengerich, F. P., Sorrells, J. L., Schmitt, S., Krauser, J. A., Aryal, P., and Meijer, L., Generation of new protein kinase inhibitors utilizing cytochrome P450 mutant enzymes for indigoid coupling, J. Med. Chem., 43, 3236-3241, 2004.
165. Jaffé, H. H. and Orchin, M., Theory and Applications of Ultraviolet Spectroscopy, John Wiley & Sons, New York, 1962.
166. Silverstein, R. M., Bassler, G. C., and Morrill, T. C., Spectrometric Identification of Organic Compounds, 5th ed., John Wiley & Sons, New York, 1991.
167. Dyer, J. R., Applications of Absorption Spectroscopy of Organic Compounds, Prentice-Hall, Englewood Cliffs, NJ, 1965.
168. 1 dialdehyde adduct formed from reaction with methylamine, Chem. Res. Toxicol., 15, 793-798, 2002.
169. Krauser, J. A., Voehler, M., Tseng, L.-H., Schefer, A. B., Godejohann, M., and Guengerich, F. P., 1ß-Hydroxylation of testosterone by human cytochrome P450 3A4, Eur. J. Biochem., 271, 3962-3969, 2004.
170. Woody, R. W., Circular dichroism, Methods Enzymol., 246, 34-71, 1995.
171. Meyring, M., Muhlbacher, J., Messer, K., Kastner-Pustet, N., Bringmann, G., Mannschreck, A., and Blaschke, G., In vitro biotransformation of (R)- and (S)-thalidomide: application of circular dichroism spectroscopy to the stere-ochemical characterization of the hydroxylated metabolites, Anal. Chem., 74, 3726-3735, 2002.
172. Rabenstein, D. L., NMR spectroscopy: past and present, Anal. Chem., 73, 214A-223A, 2001.
173. Gottlieb, H. E., Kotlyar, V., and Nudelman, A., NMR chemical shifts of common laboratory solvents as trace impurities, J. Org. Chem., 62, 7512-7515, 1997.
174. Wu, Z., Aryal, P., Lozach, O., Meijer, L., and Guengerich, F. P., Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6, Chem. Biodiversity, 2, 51-65, 2005.
175. Goeddel, D. W., Ed., Methods in Enzymology, Vol. 185, Gene Expression Technology, Academic Press, San Diego, CA, 1990.
176. Waterman, M. R. and Johnson, E. F., Methods in Enzymol-ogy, Vol. 206, Cytochrome P450, Academic Press, San Diego, CA, 1991.
177. Guengerich, F. P., Gillam, E. M. J., and Shimada, T., New applications of bacterial systems to problems in toxicology, CRC Crit. Rev. Toxicol., 26, 551-583, 1996.
178. Langouët, S., Furge, L. L., Kerriguy, N., Nakamura, K., Guillouzo, A., and Guengerich, F. P., Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, olt-ipraz and its derivatives, and sulforaphane, Chem. Res. Toxicol., 13, 245-252, 2000.
179. Parikh, A., Josephy, P. D., and Guengerich, F. P., Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties, Biochemistry, 38, 5283-5289, 1999.
180. Jensen, K. G., Poulsen, H. E., Doehmer, J., and Loft, S., Paracetamol-induced spindle disturbances in V79 cells with and without expression of human CYP1A2, Pharmacol. Toxicol., 78, 224-228, 1996.
181. Hosea, N. A., Miller, G. P., and Guengerich, F. P., Elucidation of distinct binding sites for cytochrome P450 3A4, Biochemistry, 39, 5929-5939, 2000.
182. Guengerich, F. P. and Martin, M. V., Purification of cytochrome P450: products of bacterial recombinant expression systems, in Methods in Molecular Genetics, Cytochrome P450 Protocols, Phillips, I. R. and Shephard, E., Ed., Academic Press, Orlando, FL, 2005.
183. Hanna, I. H., Dawling, S., Roodi, N., Guengerich, F. P., and Parl, F., Cytochrome P450 1B1 (CYP1B1) pharmaco-genetics: association of polymorphisms with functional differences in estrogen hydroxylation activity, Cancer Res., 60, 3440-3444, 2000.
184. Barnes, H. J., Arlotto, M. P., and Waterman, M. R., Expression and enzymatic activity of recombinant cytochrome P450 17a-hydroxylase in Escherichia coli, Proc. Natl. Acad. Sci. U.S.A., 88, 5597-5601, 1991.
185. Thier, R., Pemble, S. E., Taylor, J. B., Humphreys, W. G., Persmark, M., Ketterer, B., and Guengerich, F. P., Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes, Proc. Natl. Acad. Sci. U.S.A., 90, 8576-8580, 1993.
186. Josephy, P. D., DeBruin, L. S., Lord, H. L., Oak, J., Evans, D. H., Guo, Z., Dong, M.-S., and Guengerich, F. P., Bio-activation of aromatic amines by recombinant human cytochrome P450 1A2 expressed in bacteria: a substitute for mammalian tissue preparations in mutagenicity testing, Cancer Res., 55, 799-802, 1995.
187. Suzuki, A., Kushida, H., Iwata, H., Watanabe, M., Nohmi, T., Fujita, K., Gonzalez, F. J., and Kamataki, T., Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines, Cancer Res., 58, 1833-1838, 1998.
188. Barnes, H. J., Maximizing expression of eukaryotic cytochrome P450s in Escherichia coli, Methods Enzymol., 272, 3-14, 1996.
189. Gellissen, G., Janowicz, Z. A., Weydemann, U., Melber, K., Strasser, A. W., and Hollenberg, C. P., High-level expression of foreign genes in Hansenula polymorpha, Biotechnol. Adv., 10, 179-189, 1992.
190. Guengerich, F. P., Brian, W. R., Sari, M.-A., and Ross, J. T., Expression of mammalian cytochrome P450 enzymes using yeast-based vectors, Meth. Enzymol., 206, 130-145, 1991.
191. Loeper, J., Louérat-Oriou, B., Duport, C., and Pompon, D., Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent, Mol. Pharmacol., 54, 8-13, 1998.
192. Marques-Soares, C., Dijols, S., Macherey, A.-C., Wester, M. R., Johnson, E. F., Dansette, P. M., and Mansuy, D., Sulfaphenazole derivatives as tools for comparing cytochrome P450 2C5 and human cytochrome P450 2Cs: identification of a new high affinity substrate common to those CYP 2C enzymes, Biochemistry 42, 6363-6369, 2003.
193. Newton-Vinson, P., Hubalek, F., and Edmondson, D. E., High-level expression of human liver monoamine oxidase B in Pichia pastoris, Prot. Express. Purif., 20, 334-345, 2000.
194. Reddy, R. G., Yoshimoto, T., Yamamoto, S., and Marnett, L. J., Expression, purification, and characterization of porcine leukocyte 12-lipoxygenase produced in the methyltrophic yeast, Pichia pastoris, Biochem. Biophys. Res. Commun., 205, 381-388, 1994.
195. Brian, W. R., Srivastava, P. K., Umbenhauer, D. R., Lloyd, R. S., and Guengerich, F. P., Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae, Biochemistry 28, 4993-4999, 1989.
196. Brian, W. R., Sari, M.-A., Iwasaki, M., Shimada, T., Kaminsky, L. S., and Guengerich, F. P., Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae, Biochemistry 29, 11280-11292, 1990.
197. Miller, L. K., Baculoviruses as gene expression vectors, Annu. Rev. Microbiol., 42, 177-199, 1988.
198. Tamura, S., Korzekwa, K. R., Kimura, S., Gelboin, H. V., and Gonzalez, F. J., Baculovirus-mediated expression and functional characterization of human NADPH-P450 oxidoreductase, Arch. Biochem. Biophys., 293, 219-223, 1992.
199. Zuber, M. X., Simpson, E. R., and Waterman, M. R., Expression of bovine 17a-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells, Science, 234, 1258-1261, 1986.
200. Gonzalez, F. J., Aoyama, T., and Gelboin, H. V., Expression of mammalian cytochrome P450 using vaccinia virus, Meth. Enzymol., 206, 85-92, 1991.
201. Kimchi-Sarfaty, C., Gribar, J. J., and Gottesman, M. M., Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system, Mol. Pharmacol., 62, 1-6, 2002.
202. Gonzalez, F. J. and Kimura, S., Study of P450 function using gene knockout and transgenic mice, Arch. Biochem. Biophys., 409, 153-158, 2003.
203. Guengerich, F. P., Enzymology of rat liver cytochromes P-450, in Mammalian Cytochromes P-450, Vol. 1, Guenger-ich, F. P., Ed., CRC Press, Boca Raton, FL, 1987, pp. 1-54.
204. Guengerich, F. P., Distlerath, L. M., Reilly, P. E. B., Wolff, T., Shimada, T., Umbenhauer, D. R., and Martin, M. V., Human liver cytochromes P-450 involved in polymorphisms of drug oxidation, Xenobiotica, 16, 367-378, 1986.
205. Nebert, D. W., Nelson, D. R., Coon, M. J., Estabrook, R. W., Feyereisen, R., Fujii-Kuriyama, Y., Gonzalez, F. J., Guengerich, F. P., Gunsalus, I. C., Johnson, E. F., Loper, J. C., Sato, R., Waterman, M. R., and Waxman, D. J., The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature, DNA Cell Biol., 10, 1-14, 1991.
206. Guengerich, F. P., Hosea, N. A., Parikh, A., Bell-Parikh, L. C., Johnson, W. W., Gillam, E. M. J., and Shimada, T., Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs, Drug Metab. Dispos., 26, 1175-1178, 1998.
207. Halpert, J. R., Guengerich, F. P., Bend, J. R., and Correia, M. A., Selective inhibitors of cytochromes P450, Toxicol. Appl. Pharmacol., 125, 163-175, 1994.
208. Shimada, T. and Guengerich, F. P., Participation of a rat liver cytochrome P-450 induced by pregnenolone 16a-carbonitrile and other compounds in the 4-hydroxylation of mephenytoin, Mol. Pharmacol., 28, 215-219, 1985.
209. Guengerich, F. P., Comparisons of catalytic selectivity of cytochrome P450 subfamily members from different species, Chem. Biol. Interact., 106, 161-182, 1997.
210. Beaune, P., Kremers, P. G., Kaminsky, L. S., de Graeve, J., and Guengerich, F. P., Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes, Drug Metab. Dispos., 14, 437-442, 1986.
211. Guengerich, F. P. and Shimada, T., Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes, Chem. Res. Toxicol., 4, 391-407, 1991.
212. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines, Proc. Natl. Acad. Sci. U.S.A., 86, 7696-7700, 1989.
213. Distlerath, L. M. and Guengerich, F. P., Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs using antibodies raised to the analogous rat enzyme, Proc. Natl. Acad. Sci. USA, 81, 7348-7352, 1984.
214. Thomas, P. E., Lu, A. Y. H., West, S. B., Ryan, D., Miwa, G. T., and Levin, W., Accessibility of cytochrome P450 in microsomal membranes: inhibition of metabolism by antibodies to cytochrome P450, Mol. Pharmacol., 13, 819-831,1977.
215. Kaminsky, L. S., Fasco, M. J., and Guengerich, F. P., Production and application of antibodies to rat liver cytochrome P-450, Meth. Enzymol., 74, 262-272, 1981.
216. Soucek, P., Martin, M. V., Ueng, Y.-F., and Guengerich, F. P., Identification of a common epitope near the conserved heme-binding region with polyclonal antibodies raised against cytochrome P450 family 2 proteins, Biochemistry, 34, 16013-16021, 1995.
217. Fujino, T., Park, S. S., West, D., and Gelboin, H. V., Phe-notyping of cytochromes P-450 in human tissues with monoclonal antibodies, Proc. Natl. Acad. Sci. U.S.A., 79, 3682-3686, 1982.
218. Gelboin, H. V., Cytochrome P450 and monoclonal antibodies, Pharmacol. Rev., 45, 413-453, 1993.
219. Thomas, P. E., Reidy, J., Reik, L. M., Ryan, D. E., Koop, D. R., and Levin, W., Use of monoclonal antibody probes against rat hepatic cytochromes P-450c and P-450d to detect immunochemically related isozymes in liver microsomes from different species, Arch. Biochem. Biophys., 235, 239-253, 1984.
220. Reubi, I., Griffin, K. J., Raucy, J. L., and Johnson, E. F., Three monoclonal antibodies to rabbit microsomal cytochrome P-450 1 recognize distinct epitopes that are shared to different degrees among other electrophoretic types of cytochrome P-450, J. Biol. Chem., 259, 5887-5892, 1984.
221. Cribb, A., Nuss, C., and Wang, R., Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6, Drug Metab. Dispos, 23, 671-675, 1995.
222. Wang, R. W. and Lu, A. Y. H., Inhibitory anti-peptide antibody against human CYP3A4, Drug Metab. Dispos., 25, 762-767, 1997.
223. Baca, M., Scanlan, T. S., Stephenson, R. C., and Wells, J. A., Phage display of a catalytic antibody to optimize affinity for transition-state analog binding, Proc. Natl. Acad. Sci. USA., 94, 10063-10068, 1997.
224. Kyte, J., Mechanism in Protein Chemistry, Garland, New York, 1995.
225. Renwick, A. G., Toxicokinetics: pharmacokinetics in toxicology, in Principles and Methods of Toxicology, 3rd ed., Hayes, A. W., Ed., Raven Press, New York, 1994, pp. 101-147.
226. Andersen, M. E., Clewell, H. J., and Frederick, C. B., Applying simulation modeling to problems in toxicology and risk assessment: a short perspective, Toxicol. Appl. Pharmacol, 133, 181-187, 1995.
227. Gillam, E. M. J., Baba, T., Kim, B.-R., Ohmori, S., and Guengerich, F. P., Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme, Arch. Biochem. Biophys., 305, 123-131,1993.
228. Guengerich, F. P., Martin, M. V., Guo, Z., and Chun, Y.-J., Purification of recombinant human cytochrome P450 enzymes expressed in bacteria, Meth. Enzymol., 272, 35-44, 1996.
229. Domanski, T. L., Liu, J., Harlow, G. R., and Halpert, J. R., Analysis of four residues within substrate recognition site 4 of human cytochrome P450 3A4: role in steroid hydroxylase activity and a-naphthoflavone stimulation, Arch. Biochem. Biophys., 350, 223-232, 1998.
230. Guengerich, F. P., Hosea, N. A., and Martin, M. V., Purification of P450s. Products of bacterial recombinant systems, in Methods in Molecular Genetics, Vol. 107, Cytochrome P450 Protocols, Phillips, I. R. and Shephard, E., Eds., Academic Press, Orlando, FL, 1998, pp. 77-83.
231. Porath, J., Immobilized metal ion affinity chromatography, Prot. Express. Purif., 3, 263-281, 1992.
232. Porath, J., Carlsson, J., Olsson, I., and Belfrage, G., Metal chelate affinity chromatography, a new approach to protein fractionation, Nature, 258, 598-599, 1975.
233. Jenkins, C. M. and Waterman, M. R., Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support bovine cytochrome P450c17 hydroxylase activities, J. Biol. Chem., 269, 27401-27408, 1994.
234. Imai, T., Globerman, H., Gertner, J. M., Kagawa, N., and Waterman, M. R., Expression and purification of functional human 17alpha-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17alpha-hydroxylase/17,20-lyase deficiency, J. Biol. Chem., 268, 19681-19689, 1993.
235. Kempf, A., Zanger, U. M., and Meyer, U. A., Truncated human P450 2D6: expression in Escherichia coli: Nichelate affinity purification, and characterization of solubility and aggregation, Arch. Biochem. Biophys., 321, 277-288, 1995.
236. Sandhu, P., Baba, T., and Guengerich, F. P., Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity, Arch. Biochem. Biophys., 306, 443-450, 1993.
237. Gillam, E. M. J., Guo, Z., and Guengerich, F. P., Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties, Arch. Biochem. Biophys., 312, 59-66, 1994.
238. Gillam, E. M. J., Guo, Z., Ueng, Y.-F., Yamazaki, H., Cock, I., Reilly, P. E. B., Hooper, W. D., and Guengerich, F. P., Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5' modifications, purification, spectral characterization, reconstitution conditions, and catalytic activities, Arch. Biochem. Biophys., 317, 374-384, 1995.
239. Guo, Z., Gillam, E. M. J., Ohmori, S., Tukey, R. H., and Guengerich, F. P., Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5' substitution, stabilization, purification, spectral characterization, and catalytic properties, Arch. Biochem. Biophys., 312, 436-446, 1994.
240. Hosea, N. A. and Guengerich, F. P., Oxidation of non-ionic detergents by cytochrome P450 enzymes, Arch. Biochem. Biophys., 353, 365-373, 1998.
241. Yun, C.-H., Miller, G. P., and Guengerich, F. P., Ratedetermining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants, Biochemistry, 39, 11319-11329, 2000.
242. Kim, D. and Guengerich, F. P., Selection of human cytochrome P450 1A2 mutants with selectivity enhanced catalytic activity for heterocyclic amine N-hydroxylation, Biochemistry, 43, 981-988, 2004.
243. Hanna, I. H., Kim, M.-S., and Guengerich, F. P., Heterologous expression of cytochrome P450 2D6 mutants, electron transfer, and catalysis of bufuralol hydroxylation: the role of aspartate 301 in structural integrity, Arch. Biochem. Biophys., 393, 255-261, 2001.
244. Chun, Y.-J., Kim, S., Kim, D., Lee, S.-K., and Guengerich, F. P., A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis, Cancer Res., 61, 8164-8170, 2001.
245. 4, Nature, 227, 680-685, 1970.
246. Yasukochi, Y. and Masters, B. S. S., Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography, J. Biol. Chem., 251, 5337-5344, 1976.
247. Strobel, H. W. and Dignam, J. D., Purification and properties of NADPH-cytochrome P-450 reductase, Meth. Enzymol., 52, 89-96, 1978.
248. Guengerich, F. P., Separation and purification of multiple forms of microsomal cytochrome P-450: activities of different forms of cytochrome P-450 towards several compounds of environmental interest, J. Biol. Chem., 252, 3970-3979, 1977.
249. Guengerich, F. P., Preparation and properties of highly purified cytochrome P-450 and NADPH-cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits, Mol. Pharmacol., 13, 911-923, 1977.
250. Guengerich, F. P. and Martin, M. V., Purification of cytochrome P-450, NADPH-cytochrome P-450 reductase, and epoxide hydratase from a single preparation of rat liver microsomes, Arch. Biochem. Biophys., 205, 365-379, 1980.
251. Imai, Y., The use of 8-aminooctyl sepharose for the separation of some components of the hepatic microsomal electron transfer system, J. Biochem., 80, 267-276, 1976.
252. Imai, Y. and Sato, R., A gel-electrophoretically homogeneous preparation of cytochrome P-450 from liver microsomes of phenobarbital-pretreated rabbits, Biochem. Biophys. Res. Commun., 60, 8-14, 1974.
253. Wang, P., Mason, P. S., and Guengerich, F. P., Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver, Arch. Biochem. Biophys., 199, 206-219,1980.
254. Hanna, I. H., Teiber, J. F., Kokones, K. L., and Hollenberg, P. F., Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities, Arch. Biochem. Biophys., 350, 324-332, 1998.
255. Guengerich, F. P., Destruction of heme and hemoproteins mediated by liver microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase, Biochemistry, 17, 3633-3639, 1978.
256. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248-254, 1976.
257. Brown, R. E., Jarvis, K. L., and Hyland, K. J., Protein measurement using bicinchoninic acid: elimination of interfering substances, Anal. Biochem., 180, 136-139, 1989.
258. Furge, L. L. and Guengerich, F. P., Explanation of pre-steady-state kinetics and decreased burst amplitude of HIV-1 reverse transcriptase at sites of modified DNA bases with an additional non-productive enzyme-DNA-nucle-otide complex, Biochemistry, 38, 4818-4825, 1999.
259. Segel, I. H., Biochemical Calculations: How To Solve Mathematical Problems in General Biochemistry, 2nd ed., John Wiley & Sons, New York, 1976.
260. Einolf, H. J. and Guengerich, F. P., Kinetic analysis of nucleotide incorporation by mammalian DNA polymerase 5, J. Biol. Chem., 275, 16316-16322, 2000.
261. Bligh, E. G. and Dyer, W. J., A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol., 37, 911-917, 1959.
262. Chen, Jr., P. S., Toribara, T. Y., and Warner, H., Microdetermination of phosphorus, Anal. Chem., 28, 1756-1758, 1956.
263. Garewal, H. S., A procedure for the estimation of microgram quantities of Triton X-100, Anal. Biochem., 54, 319-324,1973.
264. Goldstein, S. and Blecher, M., The spectrophotometric assay for the polyethoxy nonionic detergents in membrane extracts: a critique, Anal. Biochem., 64, 130-135, 1975.
265. Sadano, H. and Omura, T., Reversible transfer of heme between different molecular species of microsome-bound cytochrome P-450 in rat liver, Biochem. Biophys. Res. Commun., 116, 1013-1019, 1983.
266. Black, S. D. and Coon, M. J., Comparative structures of P-450 cytochromes, in Cytochrome P-450, Ortiz de Mon-tellano, P. R., Ed., Plenum, New York, 1986, pp. 161-216.
267. Knapp, J. A., Dignam, J. D., and Strobel, H. W., NADPH-cytochrome P-450 reductase: circular dichroism and physical studies, J. Biol. Chem., 252, 437-443, 1977.
268. Dannan, G. A. and Guengerich, F. P., Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues, Mol. Pharmacol., 22, 787-794, 1982.
269. Guengerich, F. P., Artifacts in isoelectric focusing of the microsomal enzymes cytochrome P-450 and NADPH-cytochrome P-450 reductase, Biochim. Biophys. Acta, 577, 132-141, 1979.
270. Guengerich, F. P., Isolation and purification of cytochrome P-450, and the existence of multiple forms, Pharmacol. Ther., 6, 99-121, 1979.
271. O'Farrell, P. Z., Goodman, H. M., and O'Farrell, P. H., High resolution two-dimensional electrophoresis of basic as well as acidic proteins, Cell, 12, 1133-1142, 1977.
272. Vlasuk, G. P. and Walz, Jr., F. G., Liver endoplasmic retic-ulum polypeptides resolved by two-dimensional gel elec-trophoresis, Anal. Biochem., 105, 112-120, 1980.
273. Guengerich, F. P., Wang, P., and Mason, P. S., Immuno-logical comparison of rat, rabbit, and human liver NADPH-cytochrome P-450 reductases, Biochemistry, 20, 2379-2385, 1981.
274. Guengerich, F. P., Wang, P., Mason, P. S., and Mitchell, M. B., Immunological comparison of rat, rabbit, and human microsomal cytochromes P-450, Biochemistry, 20, 2370-2378, 1981.
275. Thomas, P. E., Ryan, D., and Levin, W., An improved staining procedure for the detection of the peroxidase activity of cytochrome P-450 on sodium dodecyl sulfate polyacrylamide gels, Anal. Biochem., 75, 168-176, 1976.
276. Shively, J. E., Reverse-phase HPLC isolation and microse-quence analysis, in Methods of Protein Microcharacterization, Shively, J. E., Ed., Humana Press, Clifton, NJ, 1986, pp. 41-87.
277. Shimada, T., Wunsch, R. M., Hanna, I. H., Sutter, T. R., Guengerich, F. P., and Gillam, E. M. J., Recombinant human cytochrome P450 1B1 expression in Escherichia coli, Arch. Biochem. Biophys, 357, 111-120, 1998.
278. Dong, M.-S., Bell, L. C., Guo, Z., Phillips, D. R., Blair, I. A., and Guengerich, F. P., Identification of retained N-formylmethionine in bacterial recombinant cytochrome P450 proteins with the N-terminal sequence MALĽLAVFL...: roles of residues 3-5 in retention and membrane topology, Biochemistry, 35, 10031-10040, 1996.
279. Lu, A. Y. H. and Levin, W., The resolution and reconstitution of the liver microsomal hydroxylation system, Biochim. Biophys. Acta, 344, 205-240, 1974.
280. Lu, A. Y. H., Levin, W., and Kuntzman, R., Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. VII. Stimulation of benzphetamine N-demethylation by lipid and detergent, Biochem. Biophys. Res. Commun., 60, 266-272, 1974.
281. Lu, A. Y. H., Strobel, H. W., and Coon, M. J., Hydroxyla-tion of benzphetamine and other drugs by a solubilized form of cytochrome P-450 from liver microsomes: lipid requirement for drug demethylation, Biochem. Biophys. Res. Commun., 36, 545-551, 1969.
282. French, J. S., Guengerich, F. P., and Coon, M. J., Interactions of cytochrome P-450, NADPH-cytochrome P-450 reductase, phospholipid, and substrate in the reconstituted liver microsomal enzyme system, J. Biol. Chem., 255, 4112-4119, 1980.
283. Chauret, N., Gauthier, A., and Nicoll-Griffith, D. A., Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes, Drug Metab. Dispos., 26, 1-4, 1998.
284. Ziegler, D. M., Flavin-containing monooxygenases: catalytic mechanism and substrate specificities, Drug Metab. Rev., 19, 1-32, 1988.
285. Ziegler, D. M., Recent studies on the structure and function of multisubstrate flavin-containing monooxy-genases, Annu. Rev. Pharmacol. Toxicol., 33, 179-199, 1993.
286. Ziegler, D. M., Microsomal flavin-containing monooxy-genase: oxygenation of nucleophilic nitrogen and sulfur compounds, in Enzymatic Basis of Detoxication, Vol. 1, Jakoby, W. B., Ed., Academic Press, New York, 1980, pp. 201-227.
287. Knodell, R. G., Browne, D., Gwodz, G. P., Brian, W. R., and Guengerich, F. P., Differential inhibition of human liver cytochromes P-450 by cimetidine, Gastroenterology 101, 1680-1691,1991.
288. LM4, J. Biol. Chem., 252, 3255-3261, 1977.
289. Johnson, E. F. and Muller-Eberhard, U., Multiple forms of cytochrome P-450: resolution and purification of rabbit liver aryl hydrocarbon hydroxylase, Biochem. Biophys. Res. Commun., 76, 644-651, 1977.
290. Kamataki, T., Belcher, D. H., and Neal, R. A., Studies of the metabolism of diethyl p-nitrophenyl phosphorothionate (parathion) and benzphetamine using an apparently homogeneous preparation of rat liver cytochrome P-450: effect of a cytochrome P-450 antibody preparation, Mol. Pharmacol., 12, 921-932, 1976.
291. Kaminsky, L. S., Fasco, M. J., and Guengerich, F. P., Comparison of different forms of liver, kidney, and lung microsomal cytochrome P-450 by immunological inhibition of regio- and stereoselective metabolism of warfarin, J. Biol. Chem., 254, 9657-9662, 1979.
292. Kaminsky, L. S., Fasco, M. J., and Guengerich, F. P., Comparison of different forms of purified cytochrome P-450 from rat liver by immunological inhibition of regio- and stereoselective metabolism of warfarin, J. Biol. Chem., 255, 85-91, 1980.
293. Thomas, P. E., Koreniowski, D., Ryan, D., and Levin, W., Preparation of monospecific antibodies against two forms of rat liver cytochrome P-450 and quantitation of these antigens in microsomes, Arch. Biochem. Biophys., 192, 524-532, 1979.
294. Masters, B. S. S., Baron, J., Taylor, W. E., Isaacson, E. L., and LoSpalluto, J., Immunochemical studies on electron transport chains involving cytochrome P-450. I. Effects of antibodies to pig liver microsomal reduced triphosphopy-ridine nucleotide-cytochrome c reductase and the non-heme iron protein from bovine adrenocortical mitochondria, J. Biol. Chem, 246, 4143-4150, 1971.
295. Bentley, P. and Oesch, F., Purification of rat liver epoxide hydratase to apparent homogeneity, FEBS Lett., 59, 291-295, 1975.
296. Johnson, E. F. and Muller-Eberhard, U., Resolution of two forms of cytochrome P-450 from liver microsomes of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin, J. Biol. Chem., 252, 2839-2845, 1977.
297. Johnson, E. F. and Muller-Eberhard, U., Purification of the major cytochrome P-450 of liver microsomes from rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), Biochem. Biophys. Res. Commun., 76, 652-659, 1977.
298. Knowles, R. G. and Burchell, B., A simple method for purification of epoxide hydratase from rat liver, Biochem. J., 163, 381-383, 1977.
299. Ryan, D. E., Thomas, P. E., Korzeniowski, D., and Levin, W., Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene, J. Biol. Chem., 254, 1365-1374, 1979.
300. De Lemos-Chiarandini, C., Frey, A. B., Sabatini, D. D., and Kreibich, G., Determination of the membrane topology of the phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4 using site-specific antibodies, J. Cell Biol., 104, 209-219, 1987.
301. Kawabata, T. T., Guengerich, F. P., and Baron, J., An immu-nohistochemical study on the localization and distribution of epoxide hydrolase within livers of untreated rats, Mol. Pharmacol., 20, 709-714, 1981.
302. Shen, J., Moy, J. A., Green, M. D., Guengerich, F. P., and Baron, J., Immunohistochemical demonstration of β-naph-thoflavone-inducible cytochrome P450 1A1/1A2 in rat intrahepatic biliary epithelial cells, Hepatology, 27, 1483-1491, 1998.
303. Milstein, C., From antibody diversity to monoclonal antibodies, Eur. J. Biochem., 118, 429-436, 1981.
304. Gill III, T. J., The chemistry of antigens and its influence on immunogenicity, in Imunogenicity, Borek, F., Ed., Elsevier, New York, 1972, pp. 5-44.
305. Distlerath, L. M., Reilly, P. E. B., Martin, M. V., Davis, G. G., Wilkinson, G. R., and Guengerich, F. P., Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism, J. Biol. Chem., 260, 9057-9067, 1985.
306. Shimada, T., Misono, K. S., and Guengerich, F. P., Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxi-dative drug metabolism: purification and characterization of two similar forms involved in the reaction, J. Biol. Chem., 261, 909-921, 1986.
307. Oesch, F. and Bentley, P., Antibodies against homogeneous epoxide hydratase provide evidence for a single enzyme hydrating styrene oxide and benzo(a)pyrene 4,5-oxide, Nature, 259, 53-55, 1976.
308. Park, S. S., Fujino, T., Miller, H., Guengerich, F. P., and Gelboin, H. V., Monoclonal antibodies to phenobarbital-induced rat liver cytochrome P-450, Biochem. Pharmacol., 33, 2071-2081, 1984.
309. Park, S. S., Fujino, T., West, D., Guengerich, F. P., and Gelboin, H. V., Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450, Cancer Res., 42, 1798-1808, 1982.
310. Paye, M., Beaune, P., Kremers, P., Frankinet-Collignon, C., Guengerich, F. P., Goujon, F., and Gielen, J., Quantification of two cytochrome P-450 isoenzymes by an enzyme-linked immunosorbent assay (ELISA), Biochem. Biophys. Res. Commun., 122, 137-142, 1984.
311. Guengerich, F. P., Wang, P., and Davidson, N. K., Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel elec-trophoresis, Biochemistry, 21, 1698-1706, 1982.
312. Towbin, H., Staehelin, T., and Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. U.S.A., 76, 4350-4354, 1979.
313. Shaw, P. M., Reiss, A., Adesnik, M., Nebert, D. W., Schem-bri, J., and Jaiswal, A. K., The human dioxin-inducible NAD(P)H:quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4, Eur. J. Biochem., 195, 171-176, 1991.
314. Gershoni, J. M. and Palade, G. E., Protein blotting: principles and applications, Anal. Biochem., 131, 1-15, 1983.
315. Towbin, H. and Gordon, J., Immunoblotting and dot immu-nobinding-current status and outlook, J. Immunol. Meth., 72, 313-340, 1984.
316. Steward, A. R., Dannan, G. A., Guzelian, P. S., and Guengerich, F. P., Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes, Mol. Pharmacol., 27, 125-132, 1985.
317. Simmons, D. L., McQuiddy, P., and Kasper, C. B., Induction of the hepatic mixed-function oxidase system by synthetic glucocorticoids: transcriptional and post-transcriptional regulation, J. Biol. Chem., 262, 326-332, 1987.
318. Song, B. J., Gelboin, H. V., Park, S. S., Yang, C. S., and Gonzalez, F. J., Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s: transcriptional and post-transcriptional regulation of the rat enzyme, J. Biol. Chem., 261, 16689-16697, 1986.
319. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156-159, 1987.
320. Chomczynski, P. and Mackey, K., Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation, Anal. Biochem., 225, 163-164, 1995.
321. Kingston, R. E., Chomczynski, P., and Sacchi, N., Guanidine methods for total RNA preparation, Curr. Protocols Mol. Biol., 4.2.1-4.2.9, 1996.
322. Jacobson, A., Purification and fractionation of poly(A)+ RNA, Meth. Enzymol., 152, -32768, 1987.
323. Southern, E. M., Detection of specific sequences among DNA fragments separated by gel electrophoresis, J. Mol. Biol., 98, 503-517, 1975.
324. Brown, T., Mackey, K., and Du, T., Analysis of RNA by northern and slot blot hybridization, Curr. Protocols Mol. Biol., 4.9.1-4.9.19, 2004.
325. Ogden, R. C. and Adams, D. A., Electrophoresis in agarose and acrylamide gels, Meth. Enzymol., 152, 61-87, 1987.
326. Wahl, G. M., Meinkoth, J. L., and Kimmel, A. R., Northern and Southern blots, Meth. Enzymol., 572, 581, 1987.
327. Bork, R. W., Muto, T., Beaune, P. H., Srivastava, P. K., Lloyd, R. S., and Guengerich, F. P., Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity, J. Biol. Chem., 264, 910-919, 1989.
328. Brown, T., Analysis of DNA sequences by blotting and hybridization, Curr. Protocols Mol. Biol., 2.9.1-2.9.15, 1999.
329. Birnboim, H. C. and Doly, J., A rapid alkaline extraction procedure for screening recombinant plasmid DNA, Nucl. Acids Res., 7, 1513-1523, 1979.
330. Birnboim, H. C., A rapid alkaline extraction method for the isolation of plasmid DNA, Meth. Enzymol., 100, 243-255, 1983.
331. Engelbrecht, J., Brent, R., and Kaderbhai, M. A., Minipreps of plasmid DNA, Curr. Protocols Mol. Biol., 1.6.1-1.6.10, 1991.
332. Sambrook, J. and Russell, D. W., Molecular Cloning: a Laboratory Manual, 3rd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2001.
333. Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., and Erlich, H., Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction, Cold Spring Harbor Symp. Quant. Biol., 51(Pt. 1), 263-273, 1986.
334. Kramer, M. and Coen, D. M., Enzymatic amplification of DNA by PCR: standard procedures and optimization, Curr. Protocols Mol. Biol., 15.11.11-15.11.14, 2001.
335. Kendew, J., The Encyclopedia of Molecular Biology, Blackwell Science, London, 1994.
336. Kunkel, T. A., Rapid and efficient site-specific mutagenesis without phenotypic selection, Proc. Natl. Acad. Sci. U.S.A., 82, 488-492, 1985.
337. Kunkel, T. A., Roberts, J. D., and Zakour, R. A., Rapid and efficient site-specific mutagenesis without phenotypic selection, Meth. Enzymol., 154, 367-382, 1987.
338. Vovis, G. F. and Lacks, S., Complementary action of restriction enzymes endo R-DpnI and endo R-DpnII on bacteriophage f1 DNA, J. Mol. Biol., 115, 525-538, 1977.
339. Wells, J. A., Vasser, M., and Powers, D. B., Cassette mutagenesis: an efficient method for generation of multiple mutations on defined sites., Gene, 34, 315-323., 1985.
340. Reidhaar-Olson, J. R. and Sauer, R. T., Combinatorial cassette mutagenesis as a probe of the informational content of protein sequences., Science, 241, 53-57, 1988.
341. Reidhaar-Olson, J. F., Bowie, J. U., Breyer, R. M., Hu, J. C., Knight, K. L., Lim, W. A., Mossing, M. C., Parsell, D. A., Shoemaker, K. R., and Sauer, R. T., Random mutagenesis of protein sequences using oligonucleotide cassettes, Meth. Enzymol., 208, 564-586., 1991.
342. Martin, F. H., Castro, M. M., Aboul-ela, F., and Tinoco, Jr., I., Base pairing involving deoxyinosine: implications for probe design, Nucl. Acids Res., 13, 8927-8938., 1985.
343. Schmidt-Dannert, C., Directed evolution of single proteins, metabolic pathways, and viruses, Biochemistry, 40, 13125-13136, 2001.
344. Mills, D. R., Peterson, R. L., and Spiegelman, S., An extracellular Darwinian experiment with a self-duplicating nucleic acid molecule, Proc. Natl. Acad. Sci. U.S.A., 58, 217-224, 1967.
345. Eigen, M., New concepts for dealing with the evolution of nucleic acids, Cold Spring Harbor Symp. Quant. Biol., 52, 307-320, 1987.
346. Kauffman, S., The Origins of Order: Self-Organization and Selection in Evolution, Oxford University Press, New York, 1993.
347. Chen, K. and Arnold, F. H., Tuning the activity of an enzyme for unusual environments: sequential random mutagenesis of subtilisin E for catalysis in dimethylformamide, Proc. Natl. Acad. Sci. U.S.A., 90, 5618-5622, 1993.
348. Stemmer, W. P., Rapid evolution of a protein in vitro by DNA shuffling, Nature, 370, 389-391, 1994.
349. Arnold, F. H., Design by directed evolution, Acct. Chem. Res., 31, 125-131, 1998.
350. Cirino, P. C., Mayer, K. M., and Umeno, D., Generating mutant libraries using error-prone PCR, Meth. Mol. Biol., 231, 3-9, 2003.
351. Kim, D. and Guengerich, F. P., Random mutagenesis by whole-plasmid PCR amplification, Meth. Mol. Biol., 192, 241-245, 2002.
352. Parikh, A. and Guengerich, F. P., Random mutagenesis via whole plasmid PCR amplification, BioTechniques, 24, 428-431, 1998.
353. Arnold, F. H. and Georgiou, G., Directed Enzyme Evolution, Screening and Selection Methods, Humana Press, Totowa, NJ, 2003.
354. Zhao, H., Giver, L., Shao, Z., Affholter, J. A., and Arnold, F. H., Molecular evolution by staggered extension process (StEP) in vitro recombination, Nat. Biotechnol., 16, 258-261, 1998.
355. Evans-Storms, R. B. and Cidlowski, J. A., Regulation of apoptosis by steroid hormones, J. Steroid Biochem. Mol. Biol., 53, 1-8, 1995.
356. 1, Carcinogenesis, 14, 1371-1376, 1993.
357. Yamazaki, Y., Fujita, K.-I., Nakayama, K., Suzuki, A., Nakamura, K., Yamazaki, H., and Kamataki, T., Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens, Mutat. Res., 562, 151-162, 2004.
358. White, P. A. and Rasmussen, J. B., SOS chromotest results in a broader context: empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency, Environ. Mol. Mutagen., 27, 270-305, 1996.
359. Ames, B. N., McCann, J., and Yamasaki, E., Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test, Mutat. Res., 31, 347-364, 1975.
360. Quillardet, P., Huisman, O., D'ari, R., and Hofnung, M., SOS chromotest, a direct assay of induction of an SOS function in Escherichia coli K-12 to measure genotoxicity, Proc. Natl. Acad. Sci. USA., 79, 5971-5975, 1982.
361. Quillardet, P. and Hofnung, M., The SOS chromotest, a colorimetric bacterial assay for genotoxins: procedures, Mutat. Res., 147, 65-78, 1985.
362. Valadez, J. G. and Guengerich, F. P., S-(2-chloroethyl)glutathione-generated p53 mutation spectra are influenced by differential repair rates more than sites of initial DNA damage, J. Biol. Chem., 279, 13435-13446, 2004.
363. 6-alkylguanine-DNA alkyltransferase, J. Biol. Chem., 279, 4250-4259, 2004.
364. 6-Alkylguanine-DNA alkyltransferase has opposing effects in modulating the genotoxicity of dibromomethane and bromomethyl acetate, Chem. Res. Toxicol., 17, 742-752, 2004.